Search

R01; National Institute of Neurological Disorders and Stroke Targeting the FBXW7/PGC1 Pathway as a Therapeutic Strategy for Parkinson's Disease Principal Investigator(s): David K Simon, Wenyi Wei PGC-1alpha regulates mitochondrial synthesis, and a deficiency PGC-1alpha may play a role in Parkinson’s...

Our lab focuses on unraveling the biochemistry and neuropathology underlying this complex neurodegenerative disorder. We take a systems-level approach to investigate the molecular mechanisms driving disease progression, particularly focusing on key protein pathways, including VPS35, USP30, LRRK2...

Leucine-rich repeat kinase 2 (LRRK2) is a critical protein associated with the pathogenesis of Parkinson's disease (PD), particularly through its influence on the endolysosomal system and the clearance of alpha-synuclein (aSyn) aggregates. The G2019S mutation in LRRK2 is the most prevalent...